Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Stem cells heal brain damage in mice

Country: United States

Using a combination of human neural stem cells and 3K3A-APC, a recombinant variant of human activated protein C, researchers have been able to dramatically increase the production of nerve cells in mice with stroke-induced brain damage. The findings were reported on 22 August 2016 in Nature Medicine.

Read more

Tighter human study rules

Country: United Kingdom

The European Medicines Agency is recommending a tightening of its guideline on first-in-human clinical trials to provide better protections for volunteers and a new approach to evaluating protocols that cover a number of different study parts.

Read more

Zika has impact on adult brain

Country: United States

Read more

Stroke trial follow-up

Country: United Kingdom

Read more

Analysis: Ablynx’s pipeline flourishes

Country: Belgium

Read more

AZ sells antibiotic portfolio to Pfizer

Country: United Kingdom

Read more

The brain’s sugar switch

Country: Germany

Read more

Cinven buys Bioclinica from private equity

Country: United Kingdom

Read more

Swiss Galenica to buy US company for $1.53 billion

Country: Switzerland

Read more

Amylyx raises $5 million for ALS study

Country: United States

Read more

Pfizer bids $14 billion for Medivation

Country: United States

Read more

Video consultation service gets funding

Country: Sweden

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Biophytis uses natural substances to treat ageing

Biophytis.pdf

Highlights of the July-Aug 2016 MedNous issue

The Jul-Aug 2016 MedNous features:

Latest Mednous cover
  • Research Strategy
    Multiple ways to genetically alter T cells
    By Arnaud Foussat
  • Corporate Strategy
    Treating diseases of ageing populations
    Interview with Stanislas Veillet
  • Commentary
    The power of numbers in genomics research
    By Rob Brainin
  • Research Strategy
    Liquid biopsy comes of age
    By Robin Davison
  • Financing Innovation
    Who is driving UK biotech investment?
    By Jon Rees
  • Q2 Stock Market Review

The latest MedNous journal. Subscribe to download.

Recent Appointments